|
2. Etiologie
|
|
|
|
4.1 Dép., diag. & prono. - Prostate
|
|
|
|
4.5 Dép., diag. & prono. - Colorectal
|
|
|
Low-Tech Outreach Methods Improve Colorectal Cancer Screening [NCI]
|
|
|
|
|
|
“Existing
evidence suggests no single form of colorectal cancer screening
promotion will be sufficient to achieve high rates of screening;
instead, clinicians, health care administrators, and policy makers must
work to combine different types of effective interventions.”
|
|
|
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
|
5. Traitements
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
Devastation to Puerto Rico threatens global medicine supply [Pharmafile]
|
|
|
|
|
|
Puerto
Rico became a hub for the manufacture of pharmaceuticals in the late
1960s and 1970s, taking advantage of a federal tax incentive that
allowed US-based manufacturers to avoid paying tax on profits. The
legacy still stands today and, though the industry is dwindling, the
island still produces 16 of the top 20 selling drugs for the mainland US
and seven of the top 10 drugs sold globally.
|
|
|
|
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
6.11 Patients
|
|
|
|
6.6 Publications
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
|
6.7.2 Applis
|
|
|
Apple, Verily and J&J Among 9 Selected for FDA Digital Health Pilot [RAPS]
|
|
|
|
|
|
As
part of the pilot, participants have agreed to provide access to
measures they currently use to develop, test and maintain their software
products, including the collection of post-market data. Participants
also agreed to be available for site visits from FDA staff, and provide
information about their quality management system.
|
|
|
|
|
|
|
|
6.8 Communication
|
|
|
|
6.9 Controverses
|
|
|
Award or Reward? Which comes first, NIH funding or research impact? [BioRxiv]
|
|
|
|
|
|
Which
comes first, funding or research impact? We use causal inference to
determine the direction of influence in a record of 70,000 NIH-funded
investigators, which was recently released. Contrary to the basic
premise of many funding policies, we find that the number of citations
of an investigator determine funding levels, but not the other way
around.
|
|
|
|
|
|